COVID-19 Convalescent Plasma Program

A world-renowned leader in infectious disease and transfusion medicine research, Vitalant Research Institute (VRI)—a division of Vitalant—has been at the forefront in the collection of blood plasma donations from recovered COVID-19 patients and developing technologies to detect and quantify virus-fighting antibodies. As the need for that plasma—called “convalescent plasma”—changes, Vitalant’s Convalescent Plasma Program remains robust and ready to meet customer needs.
Current Customers

Contracted customers who are part of Vitalant’s convalescent plasma program can request all convalescent products through their online ordering portal.

If you are unsure if your facility is a part of the program, please contact your account representative for guidance.

For questions regarding reimbursement for CCP products under various INDs/programs, please reach out to your Vitalant contact.

Non-contracted hospitals

Non-contracted customers who want to obtain convalescent plasma from Vitalant can reach out to Vitalant’s Inventory Management team at to discuss potential convalescent plasma ordering.

If your organization is interested in the emergency use of investigational COVID-19 convalescent plasma, we strongly recommend you visit the FDA’s webpage regarding “Recommendations for Investigational COVID-19 Convalescent Plasma” for more information about how your facility should work directly with the FDA to prepare.

ISBT Codes and Labels for customers 

For a complete list of convalescent plasma ISBT codes and labels, please click the button below:

ISBT Codes